Alimera to Present at the June 2020 Virtual Summer Investor Summit

Rhea-AI Summary

Alimera Sciences (NASDAQ: ALIM) announced that CEO Rick Eiswirth will present at the June 2020 Virtual Summer Investor Summit from June 9-12, 2020. The corporate presentation is scheduled for June 9 at 3:55 pm ET, followed by a live Q&A session with investors. A live webcast will be available here. Investors can also request one-on-one meetings with Eiswirth via email. Alimera specializes in developing treatments for retinal diseases, addressing significant unmet needs in ophthalmology.

News Market Reaction – ALIM

-0.20%

-0.20% Session move

In the trading session that priced this news, ALIM declined 0.20%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ATLANTA, June 03, 2020 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announced that Rick Eiswirth, Alimera’s President and Chief Executive Officer will give a corporate presentation at the June 2020 Virtual Summer Investor Summit taking place online from June 9- 12, 2020.

The presentation will be held on Tuesday, June 9, 2020 at 3:55 pm ET, followed by a live Q&A session with registered investors and other conference attendees. A live webcast of the presentation will be available here https://www.webcaster4.com/Webcast/Page/2038/35019. Mr. Eiswirth will be available for one-on-one meetings online as well. Interested investors may request a meeting time by emailing laura@investorsummitgroup.com.

About Alimera Sciences, Inc.

Alimera is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people globally. For more information, please visit www.alimerasciences.com.

For investor inquiries:	For media inquiries:
Scott Gordon	Jules Abraham
for Alimera Sciences	for Alimera Sciences
scottg@coreir.com	julesa@coreir.com

FAQ

When will Alimera Sciences present at the June 2020 Virtual Summer Investor Summit?

Alimera Sciences will present on June 9, 2020, at 3:55 pm ET.

Who will represent Alimera Sciences at the Investor Summit?

Rick Eiswirth, the President and CEO of Alimera Sciences, will represent the company.

How can investors access the Alimera Sciences presentation?

Investors can access the live webcast of the presentation here.

Is there an opportunity for one-on-one meetings with Alimera Sciences?

Yes, investors can request one-on-one meetings with Rick Eiswirth by emailing laura@investorsummitgroup.com.

What is the focus of Alimera Sciences?

Alimera Sciences specializes in the commercialization and development of ophthalmic treatments, specifically for retinal diseases.